20th Congress of the European Association of Urology
Patients in Bahrain suffering from a range of urological diseases and conditions, including erectile dysfunction (ED), will soon benefit from medical discoveries and new treatment therapies being discussed and debated at a major international conference, according to industry specialists.
More than 60 medical doctors from Bahrain, the highest number of any Arab nation, have just returned the prestigious 20th Congress of the European Association of Urology which took place from 16 to 19 March 2005 in Istanbul, Turkey.
During the congress, urologists, urological residents, urological scientists, and other professionals reviewed urological research as well as clinical progress and practice.
"An enormous international exchange of high quality, scientific information was made available to us through high-level meeting sessions, state-of-the-art lectures, educational courses, and focused satellite symposia," said Dr. Hamza Al Sisi.
"Of particular interest for Bahrain's doctors was a course entitled: Medical and Surgical Management of Erectile Dysfunction because we physicians in Bahrain want to learn more about the proper prescription of sildenafil, vardenafil, and tadalafil, three oral ED medications which are commonly taken in Bahrain," added Dr.Al Sissi.
Sildenafil, which Pfizer trades in the Middle East under the brand name Viagra, for example, has recently been scientifically proven to produce longer-lasting, harder erections with no side-effects, and is believed to be the number one choice among Bahraini physicians prescribing ED medication to patients.